Laura L. Johnson Kintara Therapeutics, Inc. (KTRA) insider trading activity

KTRA Quotes by TradingView

Laura L. Johnson is Director of Kintara Therapeutics, Inc.. Currently has a direct ownership of 3,000 shares of KTRA, which is worth approximately $540. The most recent transaction as insider was on Nov 22, 2021, when has been sold 3,000 shares (Common Stock) at a price of $0.74 per share, resulting in proceeds of $2,220. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3K
0% 3M change
0% 12M change
Total Value Held $540

Laura L. Johnson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 22 2021
BUY
Open market or private purchase
$2,220 $0.74 p/Share
3,000 Added 50.0%
3,000 Common Stock

Also insider at

ODTC
Odonate Therapeutics, Inc. Financial Services
Director
LJPC
LA JOLLA PHARMACEUTICAL CO Healthcare
Director
LLJ

Laura L. Johnson

Director
San Diego, CA

Track Institutional and Insider Activities on KTRA

Follow Kintara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KTRA shares.

Notify only if

Insider Trading

Get notified when an Kintara Therapeutics, Inc. insider buys or sells KTRA shares.

Notify only if

News

Receive news related to Kintara Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KTRA